Theodore E Warkentin Selected Research

argatroban (MPQA)

1/2022	How to dose and monitor argatroban for treatment of HIT.
9/2017	Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.
1/2017	Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature.
1/2016	How I treat patients with a history of heparin-induced thrombocytopenia.
10/2015	Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite "Therapeutic" Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding.
1/2014	Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls.
6/2008	Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
1/2006	Think of HIT.
9/2004	Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
5/2003	Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Theodore E Warkentin Research Topics

Disease

186	Thrombocytopenia (Thrombopenia) 01/2022 - 06/2002
71	Thrombosis (Thrombus) 01/2022 - 06/2002
30	Hemorrhage 01/2022 - 06/2002
22	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 09/2002
18	Gangrene 10/2020 - 09/2002
16	Disseminated Intravascular Coagulation 01/2022 - 01/2014
15	Critical Illness (Critically Ill) 04/2021 - 07/2005
14	Thrombophilia 01/2021 - 11/2002
12	Necrosis 01/2020 - 01/2003
11	COVID-19 01/2022 - 01/2020
11	Venous Thromboembolism 12/2021 - 01/2006
8	Infections 01/2022 - 08/2004
8	Drug-Related Side Effects and Adverse Reactions 01/2022 - 11/2002
8	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2021 - 09/2003
7	Anaphylaxis (Anaphylactic Shock) 01/2021 - 05/2005
6	Hypotension (Low Blood Pressure) 04/2021 - 09/2004
6	Ischemia 04/2021 - 01/2004
6	Sepsis (Septicemia) 01/2021 - 01/2003
5	Pulmonary Embolism 01/2022 - 02/2008
5	Shock 04/2021 - 12/2015
4	Thrombotic Thrombocytopenic Purpura 04/2022 - 12/2004
4	Transfusion Reaction 01/2020 - 09/2004
4	Neoplasms (Cancer) 11/2016 - 01/2014
4	Acute Coronary Syndrome 01/2016 - 03/2004
3	Intracranial Thrombosis (Cerebral Thrombosis) 01/2022 - 03/2003
3	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2022 - 10/2021
3	Heart Arrest (Cardiac Arrest) 01/2021 - 06/2002
3	Inflammation (Inflammations) 06/2019 - 10/2006
3	Thromboembolism 01/2017 - 04/2011
3	Thrombotic Stroke 06/2014 - 03/2005
3	Endocarditis 08/2007 - 01/2004
2	Stroke (Strokes) 01/2022 - 08/2011
2	Pain (Aches) 01/2022 - 07/2011
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2021 - 01/2003
2	Liver Diseases (Liver Disease) 04/2021 - 10/2013
2	Infarction (Infarctions) 12/2019 - 05/2009
2	Septic Shock (Toxic Shock Syndrome) 11/2019 - 12/2015
2	Wounds and Injuries (Trauma) 05/2018 - 12/2005

Drug/Important Bio-Agent (IBA)

173	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 06/2002
73	AntibodiesIBA 01/2022 - 09/2002
28	Platelet Factor 4IBA 01/2022 - 01/2005
26	AnticoagulantsIBA 01/2022 - 06/2002
24	Immunoglobulin G (IgG)IBA 01/2022 - 09/2003
20	Pharmaceutical PreparationsIBA 01/2022 - 01/2005
20	Fondaparinux (Arixtra)FDA Link 01/2020 - 06/2002
20	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2015 - 06/2002
17	VaccinesIBA 01/2022 - 01/2021
14	Warfarin (Coumadin)FDA LinkGeneric 10/2016 - 09/2002
13	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 05/2010
13	coumarinIBA 01/2011 - 09/2002
12	argatroban (MPQA)FDA Link 01/2022 - 09/2002
11	Dacarbazine (DIC)FDA LinkGeneric 12/2021 - 01/2014
11	danaparoid (Orgaran)FDA Link 01/2016 - 06/2002
10	EnzymesIBA 01/2022 - 09/2009
10	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 01/2017
10	AntithrombinsIBA 12/2021 - 06/2002
9	ChAdOx1 nCoV-19IBA 01/2022 - 01/2021
9	Thrombin FDA Link 01/2017 - 01/2003
8	bivalirudin (Angiomax)FDA Link 10/2021 - 08/2003
8	Protein CIBA 04/2021 - 01/2003
8	lepirudin (Refludan)FDA Link 06/2008 - 09/2002
6	Immunoglobulins (Immunoglobulin)IBA 10/2021 - 09/2009
6	Vitamin K FDA Link 07/2015 - 01/2004
5	ImmunosorbentsIBA 01/2022 - 09/2009
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2021 - 03/2005
5	von Willebrand FactorIBA 01/2021 - 10/2003
5	RivaroxabanIBA 01/2020 - 02/2012
5	Dalteparin (Dalteparin Sodium)FDA Link 09/2013 - 04/2011
4	AutoantibodiesIBA 04/2022 - 09/2003
4	COVID-19 VaccinesIBA 01/2022 - 10/2021
4	AntigensIBA 01/2022 - 12/2008
4	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2006
3	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2020
3	Hemostatics (Antihemorrhagics)IBA 12/2021 - 10/2003
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2020 - 08/2003
3	Factor Xa InhibitorsIBA 01/2020 - 01/2011
3	Immunoglobulin A (IgA)IBA 10/2018 - 04/2007
3	Inosine Triphosphate (ITP)IBA 04/2018 - 09/2003
3	Protamines (Protamine Sulfate)FDA Link 04/2013 - 06/2002
3	Factor Xa (Coagulation Factor Xa)IBA 02/2011 - 06/2002
3	Immunoglobulin M (IgM)IBA 08/2010 - 04/2007
2	thiamine triphosphorate (TTP)IBA 04/2022 - 12/2004
2	BNT162 VaccineIBA 01/2022 - 01/2021
2	Colloids (Colloid)IBA 04/2021 - 10/2020
2	FibrinIBA 12/2020 - 01/2020
2	LatexIBA 08/2019 - 05/2017

Therapy/Procedure

32	Therapeutics 12/2021 - 06/2002
5	Surgical Amputation (Amputations) 02/2019 - 01/2006
5	Critical Care (Surgical Intensive Care) 11/2016 - 12/2006
4	Hemodilution 04/2021 - 09/2004
4	Vascular Surgical Procedures 01/2020 - 06/2002
4	Platelet Transfusion (Blood Platelet Transfusions) 01/2019 - 08/2004
3	Orthopedic Procedures 10/2021 - 06/2002
3	Knee Replacement Arthroplasty (Total Knee Replacement) 10/2021 - 09/2017
3	Catheters 01/2020 - 06/2004
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2019 - 01/2003
3	Erythrocyte Transfusion 10/2018 - 12/2005
3	Renal Dialysis (Hemodialysis) 02/2015 - 03/2012
2	Plasma Exchange 08/2021 - 01/2015
2	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2018 - 10/2013